Introduction to a Special Issue of the Journal of Immunological Methods: Building Global Resource Programs to Support HIV/AIDS Clinical Trial Studies

dc.contributor.author

Sanchez, AM

dc.contributor.author

Denny, TN

dc.contributor.author

O'Gorman, M

dc.date.accessioned

2021-01-04T22:06:21Z

dc.date.available

2021-01-04T22:06:21Z

dc.date.issued

2014

dc.date.updated

2021-01-04T22:06:20Z

dc.description.abstract

This Special Issue of the Journal of Immunological Methods includes 16 manuscripts describing quality assurance activities related to virologic and immunologic monitoring of six global laboratory resource programs that support international HIV/AIDS clinical trial studies: Collaboration for AIDS Vaccine Discovery (CAVD); Center for HIV/AIDS Vaccine Immunology (CHAVI); External Quality Assurance Program Oversight Laboratory (EQAPOL); HIV Vaccine Trial Network (HVTN); International AIDS Vaccine Initiative (IAVI); and Immunology Quality Assessment (IQA). The reports from these programs address the many components required to develop comprehensive quality control activities and subsequent quality assurance programs for immune monitoring in global clinical trials including: all aspects of processing, storing, and quality assessment of PBMC preparations used ubiquitously in HIV clinical trials, the development and optimization of assays for CD8 HIV responses and HIV neutralization, a comprehensive global HIV virus repository, and reports on the development and execution of novel external proficiency testing programs for immunophenotyping, intracellular cytokine staining, ELISPOT and luminex based cytokine measurements. In addition, there are articles describing the implementation of Good Clinical Laboratory Practices (GCLP) in a large quality assurance laboratory, the development of statistical methods specific for external proficiency testing assessment, a discussion on the ability to set objective thresholds for measuring rare events by flow cytometry, and finally, a manuscript which addresses a framework for the structured reporting of T cell immune function based assays. It is anticipated that this series of manuscripts covering a wide range of quality assurance activities associated with the conduct of global clinical trials will provide a resource for individuals and programs involved in improving the harmonization, standardization, accuracy, and sensitivity of virologic and immunologic testing. © 2014 Elsevier B.V.

dc.identifier.issn

0022-1759

dc.identifier.issn

1872-7905

dc.identifier.uri

https://hdl.handle.net/10161/22002

dc.relation.ispartof

Journal of Immunological Methods

dc.relation.isversionof

10.1016/j.jim.2014.05.016

dc.title

Introduction to a Special Issue of the Journal of Immunological Methods: Building Global Resource Programs to Support HIV/AIDS Clinical Trial Studies

dc.type

Journal article

pubs.begin-page

1

pubs.end-page

5

pubs.organisational-group

School of Medicine

pubs.organisational-group

Duke Human Vaccine Institute

pubs.organisational-group

Duke Global Health Institute

pubs.organisational-group

Medicine, Duke Human Vaccine Institute

pubs.organisational-group

Duke

pubs.organisational-group

Institutes and Centers

pubs.organisational-group

University Institutes and Centers

pubs.organisational-group

Institutes and Provost's Academic Units

pubs.organisational-group

Medicine

pubs.organisational-group

Clinical Science Departments

pubs.volume

409

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMID24120573.pdf
Size:
376.97 KB
Format:
Adobe Portable Document Format